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Historically, one of the most controversial subjects in the manage
ment of solid malignant tumors is the impact of immediate lym
phadenectomy on overall survival Although few would argue with
the importance of regh cal node staging. the associated morbidit
has led to justifiable concern in the routine use of this procedure in
cutaneous melanoma and breast cancer, Despite substantial efforts
to identify prinia tumor characteristics that could potentially
replace the prognostic clue of the status of the regional lymph
nodes, in multivariate analxsis. the single most powerful predictor
of recurrence remains the histologic status of the regional lymph
nodes. The presence of regional nodal metastases decreases 5vcar
survival hr as much as
In the late lt)Sb’s \\ e begwi studies cx aluating the role of lx m
phatic mappine of the skin. \\e hvpothesiied that xs hen cutaneous
melanoma n etastasites xc theIr mpliatic s. u xvoulddo so to the first
draining l\ mph node. hich a as termed the ‘sentineFi mph node.
I ftechniques could be deseh ped to ideut Ix I iii its xxith metastat ic
disease in the sentinel node, then the nlaioritx of node negative
patients ci mId be spared an unnecessary diaenostic pri eedure.
Initial tudies in a iclme model deutousti’ate the feasiblitx of ultra
operative Isnipliatic napping aid our emiual manuscript iii lx—
dents xx bit eutaiieous melanoma n IPP2 established the validity of
the sentinel node hr potiesis. Current national trials are oricoinc
and dcxi gnc I to e stab Ii sh wl let her enti nc i node dissection can
impact survival in cntancon uielanoma and breast cancer.’
One of’ the benefits of entinet. staeiilv has been the ability to
perform a locLised and ‘-C itecU\ e e\amination of the reionci
node basin, Substantial cx deuce snprertsthat xehcn recional la’mph
nudes arc examined in core detail ctther hr step ccrion and.’r
innnoliistochemi5alstamnii’ an increased number ut nodeS foil
he found to harbor n1etatatte discae, In certain solid malignant
disease settings the fnidine of the “micrometastases” appears to
have provuoctic reles ailce l-Ioxxever, the routine examination of
a regional lx niphadeneciinr spec men fo both step section and
immunohistochenucal ‘tamina s both expensive and time consum
ing. For this reason, it is not r ut ic iv performed in most pathology
laboratories, Foensi cv ci the regi.onai nodes at ri.s’•k. for me.tastatic
disease to del me pm’ gmtsis. has been a strategy that see base
emplo\ ed it impros ilig staging.
Regional lx mph nodes are the most common initial site for
metastatic disease in nmost solid tumors ineludinecai’eiuoma of the
colon and recluni. (fritmcal decisions repai’dine regional and s.x
temic therapx are dependent upon ace urate taizine of the m’ecionai
lx mphatics of coloi’ectal cancer. Patients with Stage I or II cancer ot
the colon orrecmum hate an anticipated 5-r earsurvival rare in excess
of 75’ . In contrast, mdix iduals xx itlm 1 disease hate a 5-rear
surs is al ‘ate of onlr 35 bth . 1 he presence of nodal metastases
is cui’i’entlr the niost iuiportant factor in determining xx hether an
individual is a candidate for adjuvant systemic therapy.
Given the potential surgical, anatomic, and pathologic variahiliir
ins alt ed in recox eriug lx mph nodes from colorectal cancer patients.
we sought to addm’css the minimum number of nodes that needed to
he examined to accurately reflect the histology of the entire node
basin, Our repoi’t of 232 patients with colorectal cancer’ validates
that a minimal number of nodes need to he harvested and/or
examined to accurately stage the regional lymphatics in carcinoma
of the colon and rectum and establishes quality control measures that
should he instituted to accurately stage this disease Additionally.
we demonstrated tltat routinely performing a meticulous gross
examination of the resected specimen achieves nodal harvesting
numbers that are equivalent to more specialized techniques to
isolated lymph n des.
The impact of’ inadequate nodal staging is not insignificant. The
time to relapse and suit ival was signif’icantly impacted by the
number of nodes examined in node-negative individuals with rectal
cancer indicarin the heterogeneous nature of this population of’
patients. All of these patients were treated svith systemic cherno
therapr aiid pelvic n’radiation, not a clearly established standard for
node negatix e colon cancer. suggest mg that the impact on survix al
at hr insufficient node samnplmv might be even more suhstammtial in
these mdix iduals, has e demonstrated in colorecral cancer
patients that the extent ofpatholoeic assessment of’the nodal status
ot these patemits as determined by the itimibemot nodes examined
affects disc ase-tree stirs is a1. [-m’thermoi’e, it is, critically impor
tant a hen designmg clinical trials in ‘‘node negative’’ colorectal
caitcei’. that patients be stratified hr. the number of negative nodes
e samimned.
Recoguiri,ii ‘f the critical importance of nodal stagine has led lu
a nuniberuf strategies to iuipm’ove the detection of inetastatie diease
in the recional lx nphatics uf coloreetal camicer. Two fsmndamentai
ti’ate’vie has e been imrili,’ed: the first i’ to incre.ac the number ot
nodes that are cx uninc,f hr techimiqmmes such as tat clearance and the
iii an ‘h i u_h n l i 0 LitnLis j5ri I wm 1
F mph nodes a ith inure scnsiti\ e assays to ietec’t iItctastatic tunioi’
I \ ifici ii pm c miii I mIx iPi’s — i
labor ii’: orsed and c\cessi\c so’t associated xvith both appiuaches.
More cniri: ,i”ax scicarir can i,lcntit’x nuct’omci.asr,imicdc’pus
its at disease OLC the alue of “ieustaving rcmaiis conti’ox er’iai
and of nmiccrtart clinical relevance. More recently, sentinel lymph
node technoisax has been miii ed n an effort to improx e staging
accuracy iii colorccnai eai’mcer. We have descr/bed the: role of ox
sentinel node stag ugH’ F’ul low inc remova.l of the colon or r-ec.tun,
the specimen was deli verc’d t.s . pathology in the fresh state Briefly.
the fre.sti colon xx as incised loneitudina.l.ly on the anti-nies:etiteTic
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border and in the case of rectal tumors on the anterior border
opposite the Tuesolectum. ltiliiine a tuhercnl in s\ringe. tour
separate submucosal injections otapproximatel\ I I. 125cc olisosulfan
blue (Lytnphozurtn 1 4 in aqueous solution: Ben Venue Labs.
Bedford, ()H) were performed in four quadrants around the tumor.
A submucosal wheal of approximately I em as obtained. The
injection sites were then gently massaged for approximatel\ 2—5
minutes.
The ine’enterv wa then examined ha eentl incising the ox erlv
ne peritottenin at the base of the palpable nnmr and at the unction
ot the i eenterx a tb the colon. The mesenterie tat xx a’ bluntly
separated and utilizing meticulous hlnnt dissection, blue h mphatie
channels were identibed and subsequently traced through the adi
pose tissue of the mesentery to a blue stained lv mph node. These
blue stained lymph nodes were then individually harvested and
submitted for histologic e\aminjtiofl.
To date. I It t patients a t th earci m m:t f the c ut or reel u in have
been exam t ned fol h a inc or i-i xo sentinel node nappine These
patients have aneed tn ace tiotti 75) to 7 rear (mean b4 rear’. The
x ast majorit of pritnar\ tumors were either T$ 724) or T2 I ((-,
Seventy-eight percent of tumors were moderatel\ differentiated. A
mean of 3() nodes were harvested (range 5-1 Il 95fo Cl 26 to 33).
Forty-fix e patients (41 4 were found to he node positive by routine
H& F anal’, sis A totul of 2007 nodes a ore anaL ted from these 65
H&E node neeattxe specimens t I X25) non-SL\ and 275 SIN SLN
were tdenti lied itt all hut 3 speettnetis The mean nnmher of SLN
dentilied a as Xl range 0—21 (ix erall. SL\ metastases a ore
dentttied in 9 of 77X SLNs and in onl’s 4 of I 529 non—SL\s
(p<0I0 I Only two of 65 patients (3’%) of patients had evidence of
metastatic disease in non-SLN when the SLN was negative. Nine
apparentlr node negative patients l4fo) were npstaged hr IHC
staining of the SLN These results lend strong snpport tothe validit
of the senttnel node h\ pothesis in coloreetal cancer.
The identification of ‘oceulC microtnetastattc disease has raised
the isne of the hioloc ic and clinical relevance of these findings. A
tiumber ot retrospecti x e studies t n iitelanoma. breast e:nieer and
eolorectal caneer- have suggested that the detection of ecult
tTiicrometastases in regional lymph nodes is prognostically relevant.
In colorectal cancer, this remains controversial.’ It might he
reasonable to presume that mierometastatic deposits of tumor cells
identibed it regional Ir mph nodes represent :i metastatie phenotr pe
that is i dciii ieal to the metastat i c phenotype of triacrontet a static
nodal ins lx ement. and therel4te. the c-stem of n etastatie involve
mont mar not he relevaiit Flowe-ver. it is apparent that the tnetastatte
tumor burden, as reflected by the tturnher of tunior positive nodes,
correlates with outcome Patients a ith more tumor positive nodes
have a worse prognosis than individuals with fewer tumor positive
nodes Although the number of nodes involved with metastatic
tumorms Jireetlvrelated totheextent of netastatmv disease identified,
pitems may have e\temmise nodal ins olvemneni of nlv a lea rode”
while some indis dLmal’ ni ht have multiple nodes invols ed xvith
oul’s nuuimial meplacemnetit ot the node with ujetasiatie diea’e. ‘sVe
sought to address a tether direct measurement of tumor ins oLe
ment mm.ht idd to th pm ognostm ml uc ol region ml nodv st t ng
Ou.r .results fOund the mean metastat.ie. nodal tumor volu.nme xs is
5 i + T99 mm3 trance 005— 83134m.n4) was anticipated.
metastatic nodal tumor olume increased a mth the number of in-
xolved nudes. However. there was onlr a xx eak positix e correlation
xvtih number of nodes involx ed xx ith metastatie disease and mela—
static nodal tuuior volume 1 r = 0.45 . Although mdix iduals a ith
extcitsive iutnmhers of nodes involved a ith metastatie tumor olien
times have significant tumor volumes, tins xvas not uniformly the
Median lolloa up of the studr population xx-as 39 months range
I -57 months. The number of nodes involved a tilt inetastati:
disease significatitl’s impacted the actuarial 5—’sear surx ixal. The
inedt an survi x :i I of patient’ a i th 1 —3 pos mit xe node had not been
reached. In contrast those a tb 4 or inure positix 0 nudes had a
nedian survival of only 23 months, Individuals xs itlt 1—3 poOhs e
nodes had a substantially better survival than individuals with 4 or
[riot_c positive nodes (p<0.Of) 1). Furthermore, the mcmi number of
nodes involved xx ith metastatie disease in patients tree of disease
a as signitieantlx less than those xvho had died of disease 131 2.5
x s. b.7 ÷ 56. p<0.OOl).
The total rioda I vol miii to of tnetastat ie disease el wre lated xvit h
prognosis Patients xvith uiercasinc volume of metastatie disease
\xere at substannally ineteased risk of drug of recurrent disease
(p=t)Ol 9). Patients dying of disease had a substantially greater
nodal trimor volume at diagnosis than those who had not died of
disease (3705 mm-’ ± 8077 mm-k vs. 1753 mn$ ± 5239 mm.
p=0036) Hoxvever. by a stepxvise logistic regression analysis, the
total nodal x olume of melastatic disease I HR 0.999. 95(r CI ((.990
to ((.999) did not. independent of positix e nodes m.HR 441. 954 CI
117 to 1.71.)) or number of positive (HR 51). 95% (‘I 1.22 tol .Xbi
tiodes. predict oLitcome.
Twelve of 62 patients xx ith 1—3 positive nodes had onlr
micrometastatic involvement of the regional lymph nodes (<0.2mm
itt diameter). There was no difference in survival between those with
mnmcrometastatic volume disease involx enient and macrometasfalie
ol nine disease involx-ement p = 1)79 OuR tao patients xxith 4 or
more positive nodes had nodal x olume that xx as inierouietastalie. In
order to address xx lmether metastatic disease volume unght impact
surx val. xx-e str:ititied patientts xx tb 4 or more positive modes haed
upon median x olurne of motastatic in’, olx ement . Again there xx as
no difference in survival hetxveen those xx ith high metastatic nodal
volume and low metastatic nodal volume I p=0.56). These findings
suggest that mierometastatic disease is biologically relevant.
At this tinme. these approaches remain inxestigatmonal and are not
likely to he routinely applied km the eoloreetal cancer patient in the
near I utute Therefore. attenhmomi to oneologie surgical principles
and nietieuious exanmination oh the regioimal lxnmplmatmes in earcm—
nonma of the colon and rectum remains of pamramormtmt importance If
adequate node sampling is not achieved, then rigororms qualitr
control measures shruld he instituted to correct this critical deficit.
itiiproved staging can translate into improx ed onmteomes in eoloreetal
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irc got thousands 0f links it
cornpanie. And government
agencies the naryes, numbers,
advice, and connections you need
to get your wrongs righted.
Log on to
www.pueblogsa.gov, and
click on the FREE Consumer
Action ‘,Vehsite.
www.pueblo.gsa.gov
A PURLIC SERVICE OE THE
54, GENERAL SERVICES ADMINISTRAtION
F I V E WAYS a golf ball.
2. Run over by a golf cart.
TO D I E 0 N T H E 3. Whacked by a golf club.
4. Struck by lightning.GOLF COURSE: 5.Forgotyourhat.
from roelanotnu, the no.07 icC smm ci skin, cancer. if you snend a lot of time in tfr sun, you should protect yourself.
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